Agios Pharmaceuticals

AGIO

67.25

-1.48

-2.2%

After Hours:

67.25

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 68.98
Prev. Close: 68.73
Low/Hi: 67.02 - 69.43
52-Week: 39.24 - 72.73
Volumes
Equity: 397,845
90-Day Avg: 475,944
Option: 398
90-Day Avg: 342
Volatility
Todays Stock Vol: 39.3
20-Day (HV): 28.6
52-Week (HV): 52.1
30-Day IV: 55.7 +0.7
IV Pct Rank: 60% Moderate
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 3.3 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AGIO Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 138,717 200,278 160,754 285,502
Short Term Investments 447,325 279,480 380,560 293,595
Investments - - - -
Accounts Receivable 5,621 14,717 8,314 11,569
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 13,018 12,391 10,264 10,277
Net Property Plant and Equipment 24,771 24,139 25,337 26,261
Other Current Assets 0 0 0 0
Current Assets 604,681 506,866 559,892 600,943
Goodwill and Intangibles 0 0 0 0
Long Term Investments 129,899 23,423 32,250 43,499
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 760,600 557,316 619,094 672,042
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,249 2,888 1,615 1,339
Accounts Payable 23,409 16,152 17,106 15,424
Accrued Liabilities and Other Payables 29,641 25,114 32,002 22,808
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 251,608 249,936 260,503 270,593
Other Current Liabilities 40,598 41,163 39,325 39,771
Accumulated Other Comprehensive Income -650 -212 -313 29
Preferred Stock 0 0 0 0
Current Liabilities 93,648 82,429 88,433 78,003
Common Stock 48 42 42 42
Other Non-Current Liabilities 157,960 167,507 172,070 192,590
Additional Paid-In Capital 1,142,233 857,107 842,013 828,043
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -632,639 -549,557 -483,151 -426,665
Total Equity 508,992 307,380 358,591 401,449
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 160,754 71,764 14,031 71,560
Short Term Investments 380,560 245,238 328,034 95,209
Investments - - - -
Accounts Receivable 8,314 11,599 12,667 476
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 10,264 8,728 4,814 2,502
Net Property Plant and Equipment 25,337 23,220 6,386 3,758
Other Current Assets 0 0 0 0
Current Assets 559,892 337,329 359,546 169,747
Goodwill and Intangibles 0 0 0 0
Long Term Investments 32,250 58,905 125,382 27,125
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 619,094 420,065 491,904 201,205
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,615 611 590 575
Accounts Payable 17,106 14,748 11,067 3,678
Accrued Liabilities and Other Payables 32,002 15,996 14,020 8,048
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 260,503 74,947 67,538 69,723
Other Current Liabilities 39,325 22,144 36,002 25,204
Accumulated Other Comprehensive Income -313 -318 -57 14
Preferred Stock 0 0 0 0
Current Liabilities 88,433 52,888 61,089 36,930
Common Stock 42 38 37 31
Other Non-Current Liabilities 172,070 22,059 6,449 32,793
Additional Paid-In Capital 842,013 630,078 591,334 244,881
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -483,151 -284,680 -166,948 -113,444
Total Equity 358,591 345,118 424,366 131,482